← Browse by Condition
Medical Condition
breast tumors
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2
NCT06805812
Recruiting
Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study
Enrollment
3,500 pts
Location
Italy
Sponsor
Fondazione IRCCS Istituto Nazi...
NCT05582499 Phase 2
Recruiting
Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy
Enrollment
716 pts
Location
China
Sponsor
Fudan University